NESS-040C5

NESS-040C5
Clinical data
ATC code none
Legal status
Legal status
Identifiers
CAS Number 1445751-90-5
Chemical and physical data
Formula C27H33N3OS
Molar mass 447.64 g/mol
3D model (Jmol) Interactive image

NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma.[1] It has reasonable selectivity for the CB2 receptor subtype, having a CB2 affinity of 0.4nM, and 25x selectivity over the related CB1 receptor.[2]

See also

References

  1. Paolo Lazzari et al. Pharmaceutical Compounds. US Patent 8106218
  2. Hanus LO, Mechoulam R. Novel natural and synthetic ligands of the endocannabinoid system. Current Medicinal Chemistry. 2010;17(14):1341-59. PMID 20166928
This article is issued from Wikipedia - version of the 2/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.